TSHA — TAYSHA GENE THERAPIES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 216 SEC-registered investment managers reported holding TSHA (TAYSHA GENE THERAPIES INC) in their latest 13F filings, with a combined reported value of $2.13B across 310.00M shares. That is +8.0% by share count (+20.89M shares) versus the previous quarter, while reported value moved +63.6%. Ownership is concentrated: the five largest holders account for 35.3% of reported value and the top ten for 56.3%.
Compared with the prior quarter, 43 opened new positions, 102 added to existing stakes, 44 trimmed, 26 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of TAYSHA GENE THERAPIES INC (TSHA) include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Goldman Sachs Group, ranked by reported 13F value among the 366 institutional holders on this page.
TSHA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding TSHA
The superinvestors we track who report TSHA in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 503.38K | $2.45M | 0.03% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 131 | 126.65M | $616.73M | +2.2% |
| Q2 2026 | 216 | 310.00M | $2.13B | +8.1% |
| Q1 2026 | 198 | 275.28M | $1.25B | +1.9% |
| Q4 2025 | 201 | 276.94M | $1.52B | +0.8% |
| Q3 2025 | 158 | 266.23M | $870.49M | +4.7% |
| Q2 2025 | 151 | 257.49M | $594.68M | +37.4% |
| Q1 2025 | 127 | 165.87M | $230.51M | +5.2% |
| Q4 2024 | 131 | 163.72M | $283.16M | +4.7% |
Over the 8 quarters shown, institutional share counts decreased 23% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+37.4%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 22.65M | $110.32M | 0.00% | Add | |
| 15.72M | $76.57M | 0.00% | Reduce | |
| 13.56M | $66.03M | 0.00% | Add | |
| 12.54M | $61.07M | 0.00% | Hold | |
| 11.38M | $55.42M | 0.00% | Add | |
| 9.85M | $47.95M | 1.14% | Hold | |
| 6.96M | $33.91M | 0.00% | Add | |
| 3.75M | $18.26M | 0.03% | Add | |
| 3.35M | $16.29M | 0.00% | Add | |
| 3.31M | $16.13M | 0.02% | Add | |
| 3.01M | $14.66M | 0.03% | Reduce | |
| 2.30M | $11.20M | 0.05% | New | |
| 1.96M | $9.55M | 0.00% | Add | |
| 1.17M | $5.69M | 0.00% | Add | |
| 1.00M | $4.87M | 0.23% | Reduce | |
| 901.86K | $4.39M | 0.01% | Add | |
| 836.07K | $4.07M | 1.04% | Add | |
| 754.67K | $3.77M | 0.00% | Reduce | |
| 740.23K | $3.60M | 0.00% | Add | |
| 724.87K | $3.53M | 0.52% | Hold | |
| 703.83K | $3.43M | 0.01% | Add | |
| 695.41K | $3.39M | 0.00% | Add | |
| 677.36K | $3.30M | 0.00% | Add | |
| 537.63K | $2.62M | 0.00% | Add | |
| 503.38K | $2.45M | 0.03% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.89M | $162.68M | 1.46% | Add | |
| 23.56M | $160.41M | 1.39% | Hold | |
| 22.71M | $154.68M | 0.05% | Add | |
| 20.69M | $140.91M | 0.00% | Add | |
| 19.41M | $132.22M | 3.09% | Add | |
| 16.49M | $112.28M | 0.01% | Reduce | |
| 13.56M | $92.35M | 0.79% | Reduce | |
| 13.34M | $90.82M | 0.00% | Reduce | |
| 12.48M | $84.98M | 0.00% | Add | |
| 9.85M | $67.06M | 1.36% | Add | |
| 9.69M | $66.01M | 5.93% | Add | |
| 6.56M | $44.69M | 0.00% | New | |
| 6.56M | $44.69M | 0.00% | Add | |
| 5.12M | $34.85M | 0.10% | Reduce | |
| 4.50M | $30.64M | 1.87% | New | |
| 4.40M | $29.95M | 0.02% | Reduce | |
| 4.40M | $29.95M | 0.04% | Reduce | |
| 4.00M | $27.27M | 0.14% | Hold | |
| 3.98M | $27.07M | 0.01% | Add | |
| 3.98M | $27.07M | 0.01% | Add | |
| 3.89M | $26.46M | 0.04% | Add | |
| 723.18K | $24.50M | 11.86% | Reduce | |
| 3.25M | $22.13M | 1.11% | Hold | |
| 3.14M | $21.38M | 0.00% | Add | |
| 3.04M | $20.71M | 1.15% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.56M | $105.29M | 1.12% | Hold | |
| 22.37M | $99.99M | 0.04% | Add | |
| 21.70M | $97.00M | 1.18% | Hold | |
| 18.37M | $82.09M | 0.00% | Reduce | |
| 18.00M | $80.46M | 2.25% | Add | |
| 17.97M | $80.31M | 0.01% | Reduce | |
| 14.32M | $64.02M | 0.00% | Add | |
| 13.68M | $61.15M | 0.61% | Reduce | |
| 11.21M | $50.10M | 0.00% | Add | |
| 10.23M | $45.73M | 0.00% | New | |
| 8.86M | $39.60M | 4.38% | Hold | |
| 8.83M | $39.47M | 1.09% | Reduce | |
| 5.65M | $25.27M | 0.11% | Reduce | |
| 5.53M | $24.73M | 0.00% | Add | |
| 737.55K | $22.22M | 15.47% | Reduce | |
| 4.43M | $19.79M | 0.01% | Add | |
| 4.43M | $19.79M | 0.04% | Add | |
| 4.00M | $17.90M | 0.11% | Hold | |
| 3.28M | $14.67M | 0.01% | Add | |
| 3.28M | $14.67M | 0.02% | Add | |
| 3.25M | $14.53M | 1.10% | Add | |
| 2.98M | $13.32M | 0.92% | Add | |
| 2.88M | $12.89M | 0.02% | Reduce | |
| 2.72M | $12.17M | 0.16% | Hold | |
| 2.81M | $11.44M | 0.01% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.56M | $129.56M | 1.33% | Hold | |
| 21.70M | $119.35M | 1.31% | Hold | |
| 18.64M | $102.54M | 0.00% | Add | |
| 18.08M | $99.43M | 0.01% | Reduce | |
| 16.40M | $90.19M | 0.90% | Reduce | |
| 13.75M | $75.62M | 2.57% | Add | |
| 13.69M | $75.31M | 0.03% | Add | |
| 13.53M | $74.41M | 0.00% | Reduce | |
| 13.27M | $72.97M | 0.00% | Add | |
| 10.79M | $59.35M | 0.00% | Add | |
| 10.13M | $55.71M | 1.66% | Reduce | |
| 8.86M | $48.73M | 5.92% | Reduce | |
| 7.93M | $43.62M | 0.20% | Add | |
| 5.54M | $30.46M | 0.04% | Add | |
| 5.39M | $29.63M | 0.00% | Add | |
| 4.01M | $22.07M | 0.01% | Add | |
| 4.01M | $22.07M | 0.04% | Add | |
| 4.00M | $22.03M | 0.14% | Hold | |
| 3.87M | $21.28M | 0.08% | Reduce | |
| 3.72M | $20.47M | 0.04% | New | |
| 3.30M | $18.15M | 1.11% | Add | |
| 3.18M | $17.48M | 0.01% | Reduce | |
| 3.18M | $17.48M | 0.03% | Add | |
| 2.72M | $14.97M | 0.21% | Reduce | |
| 2.50M | $13.73M | 1.06% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 24.35M | $79.64M | 0.98% | Reduce | |
| 23.56M | $77.03M | 0.95% | Hold | |
| 21.70M | $70.96M | 1.05% | Hold | |
| 19.31M | $63.14M | 0.00% | Add | |
| 16.36M | $53.51M | 0.00% | Add | |
| 14.59M | $47.72M | 0.00% | Reduce | |
| 13.38M | $43.76M | 0.02% | Add | |
| 12.85M | $42.02M | 0.00% | Add | |
| 11.01M | $36.02M | 1.41% | Hold | |
| 9.07M | $29.65M | 4.63% | Reduce | |
| 7.33M | $23.97M | 0.10% | Hold | |
| 7.24M | $23.66M | 0.00% | Add | |
| 5.50M | $17.98M | 0.81% | Add | |
| 5.39M | $17.61M | 0.28% | Hold | |
| 5.29M | $17.31M | 0.09% | Add | |
| 5.17M | $16.92M | 0.00% | Add | |
| 5.15M | $16.83M | 0.02% | Add | |
| 4.63M | $15.15M | 0.01% | Add | |
| 4.00M | $13.10M | 0.10% | Hold | |
| 3.33M | $10.88M | 0.02% | Reduce | |
| 3.00M | $9.81M | 0.95% | Add | |
| 2.84M | $9.27M | 0.95% | Reduce | |
| 2.71M | $8.85M | 0.02% | Add | |
| 2.71M | $8.85M | 0.01% | Add | |
| 2.16M | $7.05M | 0.09% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 25.02M | $57.80M | 0.82% | Add | |
| 23.56M | $54.41M | 0.92% | Add | |
| 21.70M | $50.13M | 0.88% | Add | |
| 16.87M | $38.96M | 0.00% | Hold | |
| 15.63M | $36.10M | 0.00% | Hold | |
| 13.30M | $30.73M | 0.00% | Reduce | |
| 12.59M | $29.09M | 6.38% | Add | |
| 12.59M | $29.08M | 0.01% | Add | |
| 11.01M | $25.44M | 1.32% | Add | |
| 10.89M | $25.17M | 0.00% | Add | |
| 10.31M | $23.82M | 0.50% | Add | |
| 7.32M | $16.90M | 0.08% | Add | |
| 5.39M | $12.44M | 0.24% | New | |
| 5.14M | $11.87M | 0.00% | Add | |
| 5.00M | $11.55M | 0.06% | Add | |
| 4.84M | $11.18M | 0.02% | New | |
| 4.73M | $10.92M | 0.04% | New | |
| 4.00M | $9.25M | 0.09% | Hold | |
| 3.79M | $8.77M | 0.00% | Add | |
| 3.22M | $7.43M | 0.23% | New | |
| 3.01M | $6.95M | 1.16% | Add | |
| 3.00M | $6.93M | 0.36% | New | |
| 2.95M | $6.82M | 1.18% | New | |
| 2.94M | $6.78M | 0.01% | Add | |
| 2.94M | $6.78M | 0.00% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 6.56M sh · $44.69M
- MPM BioImpact LLC 4.50M sh · $30.64M
- Farallon Capital Management 2.25M sh · $15.32M
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.25M sh · $15.32M
- Sixth Street Partners Management Company, L.P. 2.20M sh · $14.99M
- ORBIMED ADVISORS LLC 2.00M sh · $13.62M
- HEIGHTS CAPITAL MANAGEMENT, INC 1.50M sh · $10.21M
- FIRST TRUST ADVISORS LP 791.17K sh · $5.39M
- AFFINITY WEALTH MANAGEMENT LLC 576.81K sh · $3.93M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 553.00K sh · $3.77M
- DIADEMA PARTNERS LP 522.62K sh · $3.56M
- Holocene Advisors, LP 510.00K sh · $3.47M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 11.21M sh · $50.10M
- DEERFIELD MANAGEMENT COMPANY, L.P. sold 2.72M sh · $12.17M
- Point72 Asset Management sold 461.86K sh · $2.06M
- Renaissance Technologies sold 413.20K sh · $1.85M
- SUPERSTRING CAPITAL MANAGEMENT LP sold 258.27K sh · $1.15M
- TUDOR INVESTMENT CORP ET AL sold 143.57K sh · $641.78K
- Janus Henderson Group sold 69.00K sh · $308.08K
- VARCOV Co. sold 58.51K sh · $261.54K
- Abacus Wealth Partners, LLC sold 58.24K sh · $260.34K
- Legato Capital Management LLC sold 21.78K sh · $97.37K
- Scientech Research LLC sold 21.04K sh · $94.05K
- Catalyst Funds Management Pty Ltd sold 15.10K sh · $67.50K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 22.65M | 20.69M | 18.37M | 18.64M | 16.36M | 13.30M | 13.59M | 13.53M | 13.52M | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 15.72M | 16.49M | 17.97M | 18.08M | 19.31M | 16.87M | 16.85M | 17.64M | 7.66M | 7.48M | 5.17M | 216.54K | 172.07K | 131.31K | 87.81K | 23.61K | 24.96K | 71.65K | 175.75K | 142.34K |
| Fidelity Management & Research (FMR) | 13.56M | 13.34M | 14.32M | 13.53M | 14.59M | 15.63M | 15.63M | 16.37M | 18.68M | 21.21M | 20.11M | 22.44M | 24.53M | 1.15M | 3.09M | 3.20M | 3.29M | 3.30M | 3.29M | 4.28M |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.54M | 12.48M | 10.23M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 11.38M | — | 11.21M | 10.79M | 7.24M | 5.14M | 3.23M | 6.47M | 3.47M | 3.32M | 339.52K | 143.22K | 140.02K | — | — | — | — | — | — | — |
| Siren, L.L.C. | 9.85M | 9.85M | 8.83M | 10.13M | 11.01M | 11.01M | 6.51M | 6.60M | 4.88M | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 6.96M | 6.56M | 5.53M | 5.39M | 5.17M | 3.79M | 3.66M | 3.57M | 3.56M | 2.88M | 1.02M | 985.42K | 461.67K | 357.85K | 376.46K | 331.74K | 240.41K | 238.24K | 409.57K | 390.85K |
| Aberdeen Group plc | 3.75M | 2.33M | 1.02M | 1.02M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.35M | 3.14M | 2.02M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 3.31M | 2.77M | 19.32K | 19.32K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.01M | 3.89M | 2.88M | 3.72M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 2.30M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.96M | 1.90M | 1.53M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 1.17M | 791.17K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 1.00M | 1.75M | 1.00M | 3.30M | 3.00M | 200.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 901.86K | 259.61K | — | — | — | — | — | — | 352.68K | 632.50K | 1.07M | 118.52K | — | — | — | — | — | — | — | — |
| Quantum Private Wealth, LLC | 836.07K | 812.03K | 849.21K | 819.72K | 822.08K | 815.98K | 791.48K | 794.98K | 767.62K | 730.52K | 698.52K | 639.52K | 575.38K | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 754.67K | 766.28K | 754.78K | 774.41K | 296.24K | 222.65K | 1.00M | 2.64M | 3.00M | 2.96M | 93.74K | 36.48K | 137 | 1.78K | 1.78K | 1.78K | 44.56K | 279.29K | 439.80K | 237.56K |
| BNY Mellon | 740.23K | 697.97K | 608.12K | 624.37K | 624.84K | 458.66K | 453.42K | 450.26K | 338.27K | 454.46K | — | 58.14K | 26.07K | — | — | — | 11.29K | 11.67K | 78.24K | 76.17K |
| Sands Capital Alternatives, LLC | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | 724.87K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TSHA?
As of 2026-Q2, 216 institutional funds reported holding TSHA (TAYSHA GENE THERAPIES INC) in SEC 13F filings, with a combined reported value of $2.13B.
How many shares of TSHA do institutions own?
13F filers reported 310.00M shares of TSHA, worth $2.13B in aggregate at the end of 2026-Q2.
Is institutional ownership of TSHA rising or falling?
Share counts moved +8.0% versus the prior quarter — accumulation.
Who are the top institutional holders of TSHA?
The largest 13F holders are Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Goldman Sachs Group, Vestal Point Capital, LP, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of TAYSHA GENE THERAPIES INC?
The major shareholders of TAYSHA GENE THERAPIES INC (TSHA) by reported 13F value are Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Goldman Sachs Group, Vestal Point Capital, LP, BlackRock Inc, among 366 institutional holders.
Which legendary investors own TSHA?
1 of the legendary investors tracked on HoldingsHub report TSHA (TAYSHA GENE THERAPIES INC) in their latest 13F filings, led by Polen Capital Management. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on TSHA?
1 tracked superinvestors hold TSHA simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.